HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus

Diabetic Medicine

Volumn 13, Issue 3, 1996, Pages 209-217

  Sanjeevi, C B ^a   Falorni, A ^a   Kockum, I ^a   Hagopian, W A ^b   Lernmark, A ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Genetic susceptibility; Glutamate decarboxylase 65; HLA DQ; HLA DR; Insulin dependent diabetes mellitus

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE AUTOANTIBODY; HLA ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHROMOSOME 6; ETHNOLOGY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; FEMALE; GENOMIC IMPRINTING; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE;

EID: 0030007294     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199603)13:3<209::AID-DIA39>3.0.CO;2-2     Document Type: Article

References (68)

1. LaPorte RE, Tajima N, Åkerblom HK, Berlin N, Brosseau J, Christy M, et al. Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 1985; 8: 101-107.
2. Palmer JP, Lernmark. Pathophysiology of type 1 (insulin-dependent) diabetes. In: Rifkin H, Porte D, eds. Ellenberg and Rifkin's Diabetes Mellitus; Theory and Practice. New York: Elsevier, 1990: 414-435.
3. Eisenbarth GS. Type 1 diabetes mellitus. A chronic autoimmune disease. New Engl J Med 1986; 314: 1360-1368.
4. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619-633.
5. Foulis AK, McGill M, Farquharson A. Insulitis in Type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes, and interferon-λ containing cells. J Pathology 1991; 165: 97-103.
6. Lernmark Å, Klöppel G, Stenger D, Vathanaprida C, Fält K, Landin-Olsson M, et al. Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Archives 1995; 425: 631-640.
7. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 1279-1283.
8. Landin-Olsson M, Palmer JP, Lernmark Å, Blom L, Sundkvist G, Nyström L, et al. Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a popoulation-based study of newly diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068-1073.
9. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167-169.
10. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
11. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci US 1991; 88: 8337-8341.
12. r isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-636.
13. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339.
14. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
15. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system, 1994. Tissue Antigens 1994; 44: 1-18.
16. Wassmuth R, Lernmark Å. The genetics of susceptibility to diabetes. Clin Immunol Immunopathol 1990; 53: 358-399.
17. Todd JA, Acha-Orbea H, Bell JL, Chao N, Fronek Z, Jacob CO et al. A molecular basis for MHC class II-associated autoimmunity. Science 1988; 240: 1003-1009.
18. Rønningen KS, Sprukland A, Iwe T, Vartdal F, Thorsby E. Distribution of HLA-DRB, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991; 37: 105-111.
19. Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA, et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2 positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994; 44: 110-119.
20. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in Type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Human Genet 1993; 53: 150-167.
21. Nepom GT. Immunogenetics and IDDM. Diabetes Reviews 1993; 1: 93-103.
22. Sanjeevi CB, Lybrand T, DeWeese C, Landin-Olsson M, Kockum I, Dahlqvist G, et al. Polymorphic aminoacid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes 1995; 44: 125-131.
23. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Dkilali-Saiah I, et al. Age dependent HLA genetic heterogeniety of Type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242-2250.
24. Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlqvist G, Lernmark Å. Effects of the second haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 1995; 45: 148-152.
25. Rønningen KS, Spurkland A, Tait BD, Drummond B, Lopez-Larrea C, Baranda FS, et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese. In Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1997 - Proceedings of the Eleventh International Histocompatibility Workshop and Conference, vol 1. Oxford: Oxford University Press, 1991: 713-722.
26. Vandewalle CL, Decraene T, Schuit FC, De-Leeuw IH, Pipeleers DG, Gorus FK. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry. Diabetologia 1993; 36: 1155-1162.
27. Thorsby E, Rønningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 371-377.
28. Kwok WA, Kovats S, Thurtle P, Nepom GT. HLA-DQ allelic polymorphisms constrain patterns of class Il heterodimer formation. J. Immunol 1993; 150: 2263-2272.
29. Rønningen KS, Markussen G, Iwe T, Thorsby E. An increased risk of insulin-dependent diabetes mellitus (IDDM among HLA-DR4, DQw8/DR8, DQw4 heterozygotes. Hum Immunol 1989; 24: 165-173.
30. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. New Engl J Med 1990; 322: 1836-1882.
31. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J. Dose effect of cis- and trans-encoded HLA-DQαβ heterodimers in IDDM susceptibility. Diabetes 1992; 41: 378-384.
32. Cucca F, Muntoni F, Lampis R, Frau F, Argioias L, Silvetti M et al. Combinations of specific DRBI, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Human Immunol 1993; 37: 85-94.
33. Todd JA, Bell JI, McDevitt HO. HLA DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604.
34. Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, et al. Aspartic acid in position 57 of DQβ chain does not protect against Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1989; 32: 762-764.
35. Penny M, Mijovic C, Cavan D, Jacobs K, Jenkins D, Fletcher J, et al. An investigation of the association between HLA-DQ heterodimer and Type1 diabetes in five racial groups. Hum Immunol 1993; 38: 179-183.
36. Sanjeevi CB, Zeidler A, Shaw S, Rotter J, Nepom GT, Costin C, et al. Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus. Tissue Antigens 1993; 38: 72-77.
37. Reijonen H, Ilonen J, Åkerblom H, Knip M, Dosch H-M. Multilocus analysis of HLA class II genes in DR2 positive IDDM haplotypes in Finland. Tissue Antigens 1994; 43: 1-6.
38. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans racial gene mapping. Nature 1989; 338: 587-589.
39. Todd JA, Fukui Y, Kitagawa T, Sasazuki T. The A3 allele of the HLA DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc. Natl. Acad. Med. Sci USA 1990; 87: 1094-1098.
40. Jacobs KH, Jenkins D, Mijovic C, Penny M, Uchigata Y, Cavan D, et al. An investigation of Japanese subjects maps susceptibility to Type 1 (insulin-dependent) diabets mellitus close to the DQA1 gene. Human Immunol 1992; 33: 24-28.
41. Sanjeevi CB, Landin-Olsson M, Kockum I, Lernmark Å. Several residues in the DQA1 and DQB1 chain are either positively or negatively associated with insulin-dependent diabetes mellitus (abstract). Diabetes 1995; 44: suppl 1 241A.
42. Stern LJ, Brown JH, Jardetsky TS, Gorga JC, Urban RG, Stominger JL, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994; 368: 215-221.
43. Grubin C, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood insulin-dependent diabetes mellitus. Diabetologia 1994; 37: 344-350.
44. Hagopian WA, Karlsen AE, Gottsäter, Landin-Olsson M, Grubin CE, Sundkvist GA, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) shows 64K autoantibody positively at onset predicts diabetes type. J Clin Invest 1993; 91: 368-374.
45. Hagopian W, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, et al. Glutamate decarboxylase, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-1511.
46. Falorni A, Grubin C, Takei I, Shimada A, Kasuga A, Murayama T, et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-125.
47. Serjeantson SW, Kohonen-Corish MRJ, Rowley MJ, Mackay IR, Knowles W, Zimmet P. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 996-1001.
48. Bu D-F, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wanger-McPherson CB, et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci 1992; 89: 2115-2119.
49. Lernmark Å, Hägglöf B, Freedman Z, Irvine J, Ludvigsson J, Holmgren G. A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia 1981; 20: 471-474.
50. Solimena M, Folli F, Dendis-Donini S, Comi G, Pozza G, DeCamilli P, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy and Type 1 diabetes. N Engl J Med 1988; 318: 1012-1020.
51. 3H recombinant human ligands. J Immunol Methods 1995; 186: 89-99.
52. Vandewalle C, Falorni A, Svanholm S, Lernmark Å, Pipeleers D, Gorus F. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between 20 and 40 years. J Clin Endo Metab 1995; 80: 846-851.
53. Falorni A, Svanholm S, Vandewalle C, Örtqvist E, Persson B, Lernmark Å. Seasonal variation of GAD65 autoantibodies at onset of insulin-dependent diabetes mellitus, in relation to gender (Abstract). Diabetologia 1994; 37 (suppl 1): A56.
54. Richter W, Shi Y, Baekkeshov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993; 90: 2832-2836.
55. Daw K, Powers A. Two distinct glutamic acid decarboxylase auto antibody specificities in IDDM target different epitopes. Diabetes 1995; 44: 216-220.
56. Kaufman D, Erlander MG, Clare-Salzer M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.
57. Tisch R, Yang X, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72-75.
58. Kaufman D, Clare-Salzar M, Tian L, Forsthuber T, Ting GS, Robinson P, et al. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72.
59. Clare-Salzer M, Tobin A, Kaufman D. Glutamate decarboxylase: an autoantigen in IDDM. Diabetes Care 1992; 15: 132-135.
60. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D-F, et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458-459.
61. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M. immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent mellitus. Lancet 1994; 343: 1607-1608.
62. Kawasaki E, Takino H, Yano M, Uotani S, Matsomoto K, Takao Y, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994; 43: 80-86.
63. Sanjeevi C, Höök P, Hagopian W, Landin-Olsson M, Kockum I, Dahlquist G, et al. Correlation of antibody markers to subtypes of HLA-DR4 in insulin-dependent diabetes mellitus (Abstract). Diabetologia 1994; 37 (suppl 1): A84.
64. Kasuga A, Falorni A, Maruyama T, Grubin CE, Borch A, Ozawa Y, et al. Glutamic acid decarboxylase Mr 65000 autoantibody and HLA class II in Japanese IDDM. 15th International Diabetes Federation Congress, Kobe 1994 -Abstracts 1994; 07A5PP0160: 194.
65. Serjeantson S, Court J, Mackay I, Matheson B, Rowley MJ, Tuomi T, et al. HLA-DQ genotypes are associated with aotuimmunity to glutamic acid decarboxylase in insulin-dependent diabetes patients. Human Immunol 1993; 38: 97-104.
66. Sanjeevi CB, Hagopian W, Landin-Olsson M, Kockum I, Dahlquist G, Palmer JP, et al. Different DQ genotypes are associated in antibody marker positive and negative insulin-dependent diabetes patients (Abstract). Diabetologia 1995; 38 (suppl 1): A89.
67. Vandewalle C, Falorni A, Lernmark, Van der Auwera B, Schuit F, Pipeleers D, et al. GAD65-antibodies are associated with HLA-DQ susceptibility in adult but not in young Type 1 diabetic patients (Abstract). Diabetologia 1995; 38(suppl 1): A55.
68. Petersen J, Hejnaes K, Moody A, Karlsen AE, Marshall MO, Høier-Madsen M, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-467.